Overdiagnosis and overtreatment of early detected prostate cancer

Por Bangma, C. H., Roemeling, S., Schröder, F. H.
Publicado em 2007

Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer

Por van Weerden, W M, Bangma, C, de Wit, R
Publicado em 2009

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

Por Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Publicado em 2012

Men's preferences for prostate cancer screening: a discrete choice experiment

Por de Bekker-Grob, E W, Rose, J M, Donkers, B, Essink-Bot, M-L, Bangma, C H, Steyerberg, E W
Publicado em 2013

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors

Por Wever, E M, Heijnsdijk, E A M, Draisma, G, Bangma, C H, Roobol, M J, Schröder, F H, de Koning, H J
Publicado em 2013

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment

Por de Bekker-Grob, E W, Bliemer, M C J, Donkers, B, Essink-Bot, M-L, Korfage, I J, Roobol, M J, Bangma, C H, Steyerberg, E W
Publicado em 2013

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xen...

Por Schroeder, Rogier P. J., van Weerden, W. M., Krenning, E. P., Bangma, C. H., Berndsen, S., Grievink-de Ligt, C. H., Groen, H. C., Reneman, S., de Blois, E., Breeman, W. A. P., de Jong, M.
Publicado em 2011

Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

Por Heijnsdijk, E. A. M., de Carvalho, T. M., Auvinen, A., Zappa, M., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., Tammela, T. L. J., Recker, F., Denis, L., Carlsson, S.V., Wever, E. M., Bangma, C. H., Schröder, F. H., Roobol, M. J., Hugosson, J., de Koning, H. J.
Publicado no J Natl Cancer Inst (2014)

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

Por Mitra, Anita V., Bancroft, Elizabeth K., Barbachano, Yolanda, Page, Elizabeth C., Foster, C. S., Jameson, C., Mitchell, G., Lindeman, G. J., Stapleton, A., Suthers, G., Evans, D. G., Cruger, D., Blanco, I., Mercer, C., Kirk, J., Maehle, L., Hodgson, S., Walker, L., Izatt, L., Douglas, F., Tucker, K., Dorkins, H., Clowes, V., Male, A., Donaldson, A., Brewer, C., Doherty, R., Bulman, B., Osther, P. J., Salinas, M., Eccles, D., Axcrona, K., Jobson, I., Newcombe, B., Cybulski, C., Rubinstein, W. S., Buys, S., Townshend, S., Friedman, E., Domchek, S., Ramon y Cajal, T., Spigelman, A., Teo, S. H., Nicolai, N., Aaronson, N., Ardern-Jones, A., Bangma, C., Dearnaley, D., Eyfjord, J., Falconer, A., Grönberg, H., Hamdy, F., Johannsson, O., Khoo, V., Kote-Jarai, Z., Lilja, H., Lubinski, J., Melia, J., Moynihan, C., Peock, S., Rennert, G., Schröder, F., Sibley, P., Suri, M., Wilson, P., Bignon, Y. J., Strom, S., Tischkowitz, M., Liljegren, A., Ilencikova, D., Abele, A., Kyriacou, K., van Asperen, C., Kiemeney, L., Easton, D. F., Eeles, Rosalind A.
Publicado no BJU Int (2010)